Mednet Logo
HomeQuestion

Would you offer adjuvant chemotherapy for MSI-H Stage II colon cancer with multiple high risk features?

5
2 Answers
Mednet Member
Mednet Member
Medical Oncology · Columbia University College of Physicians and Surgeons

About 15-20% of colorectal cancers are found to be MSI-high. These tumors are generally associated with a superior prognosis to those who are MSI-stable. Thus, the question as to whether one should utilize adjuvant chemotherapy in the context of patients with stage II disease, a setting where adjuva...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Medical Oncology · Columbia University College of Physicians and Surgeons

I appreciate the cogent responses to my initial answer to the query above. Just to respond to a couple of the points raised:

If there were a tumor deposit in the original tumor specimen, then this would no longer be a stage II tumor, and I would certainly agree with the need for adjuvant chemotherap...

Register or Sign In to see full answer